Brand Names

Category

• Monoclonal antibody
• antineoplastic - radioactive

Description Drug

Ibritumomab Tiuxetan - ib-ri-TU-moe-mab - tie-ux-EH-tan is a protein called a monoclonal antibody. It is using along with another monoclonal antibody - rituximab and two radioactive pharmaceuticals - In-111 and Y-90. Ibritumomab tiuxetan is using to treat a type of cancer called non-Hodgkin's lymphoma.

Ibritumomab Tiuxetan is to be aplaying only by or under the immediate supervision of your family doctor. It is available in the following dosage form:

Parenteral
• Injection - USA

Brand Names

Some commonly using brand names are:

In the USA

• Zevalin

Other commonly using names are:

• IDEC-2B8 - ibritumomab tiuxetan
• IDEC-Y2B8 - yttrium-90-ibritumomab tiuxetan
• IDEC-In2B8 - indium-111-ibritumomab tiuxetan
• IDEC-129

† Not commercially available in Canada.